Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Medexus Pharmaceuticals Enters into Expanded Licensing Agreement for Gliolan in Canada

March 4 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS ENTERS INTO EXPANDED LICENSING AGREEMENT FOR
GLIOLAN® IN
CANADA
    * MEDEXUS PHARMACEUTICALS INC -MEDEXUS PLANS TO FILE FOR
REGISTRATION OF GLIOLAN WITH HEALTH CANADA IN 2019
    * MEDEXUS PHARMACEUTICALS INC-EXPECTS TO RECEIVE FULL
REGISTRATION
OF GLIOLAN WITHIN 12 TO 18 MONTH FOLLOWING APPLICATION

Source text for Eikon:  ID:nGNX5nLDMh 
Further company coverage:  MDP.V 

 (((Reuters.Briefs@thomsonreuters.com);;))

Recent news on Medexus Pharmaceuticals

See all news